Skip to main content
SpringerLink
Log in

Statins, Regulatory T Cells and Amyotrophic Lateral Sclerosis

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Edwards IR, Star K, Kiuru A. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from Vigibase. Drug Saf 2007; 30(6): 515–25

    Article  PubMed  Google Scholar 

  2. LaRosa JC. Low-density lipoprotein cholesterol reduction: the end is more important than the means. Am J Cardiol 2007; 100: 240–2

    Article  PubMed  CAS  Google Scholar 

  3. Mausner-Fainberg K, Luboshits G, Mor A, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis. Epub 2007 Sept 10

  4. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16: 518–24

    Article  PubMed  CAS  Google Scholar 

  5. Kipnis J, Mizrahi T, Hauben E, et al. Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc Natl Acad Sci 2002; 99: 15620–5

    Article  PubMed  CAS  Google Scholar 

  6. Pacheco R, Gallart T, Lluis C, et al. Role of glutamate on T-cell mediated immunity. J Neuroimmunol 2007; 185: 9–19

    Article  PubMed  CAS  Google Scholar 

  7. Kipnis J, Yoles E, Mizrahi T, et al. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J Neuroimmunol 2002; 130: 78–85

    Article  PubMed  CAS  Google Scholar 

  8. Schwartz M, Kipnis J. A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostatis. Trends in Pharm Sci 2004; 25: 407–12

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors have no conflicts of interest that are directly relevant to the content of this letter.

Author information

Authors and Affiliations

  1. Fountain Medical Court, Bonita Springs, Florida, USA

    Mark R. Goldstein

  2. Comando Brigata Alpina “Julia”, Servizio Sanitario, Udine, Italy

    Luca Mascitelli

  3. Cardiology Service, Ospedale di Tolmezzo, Tolmezzo, Italy

    Francesca Pezzetta

Authors
  1. Mark R. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Mascitelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Pezzetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldstein, M.R., Mascitelli, L. & Pezzetta, F. Statins, Regulatory T Cells and Amyotrophic Lateral Sclerosis. Drug-Safety 31, 181–182 (2008). https://doi.org/10.2165/00002018-200831020-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831020-00007

Keywords

Search

Navigation